Nobel recognition renews attention on optogenetics as a foundational neurotechnology

The 2026 Nobel Prize in Medicine reportedly recognizes the discovery and development of optogenetics, including channelrhodopsin and neural circuit-control work associated with Karl Deisseroth and collaborators. The award highlights optogenetics' influence on modern neurotechnology and possible vision and cochlear applications, while human translation, safety, ethics, and clinical evidence remain limited.